Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Acq. announced

ZEVRA THERAPEUTICS, INC. (KMPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
08/25/2023 4 Anderson Thomas (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Granted 58,800 options to buy @ $0
08/24/2023 3 Anderson Thomas (Director) has filed a Form 3 on ZEVRA THERAPEUTICS, INC.
06/30/2023 4 Schafer Joshua (CCO & EVP, Bus. Development) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Bought 1,000 shares @ $5.4157, valued at $5.4k
06/02/2023 4 FAVORITO TAMARA A (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Granted 10,000 options to buy @ $0
05/31/2023 4 Watton Corey Michael (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Bought 400 shares @ $5.1053, valued at $2k
05/19/2023 4 Bode John B (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Bought 1,390 shares @ $5.035, valued at $7k
Bought 300 shares @ $5.0391, valued at $1.5k
Bought 1,000 shares @ $5.0399, valued at $5k
Bought 4,759 shares @ $5.04, valued at $24k
Bought 100 shares @ $5.045, valued at $504.5
Bought 2,451 shares @ $5.05, valued at $12.4k
05/18/2023 4 Clifton R. LaDuane (CFO, Secretary & Treasurer) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Bought 51 shares @ $4.94, valued at $251.9
Bought 2,000 shares @ $4.9499, valued at $9.9k
Bought 689 shares @ $4.9495, valued at $3.4k
05/11/2023 4 Calder Douglas W (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Granted 58,800 options to buy @ $0
05/11/2023 3 Calder Douglas W (Director) has filed a Form 3 on ZEVRA THERAPEUTICS, INC.
05/08/2023 4 Watton Corey Michael (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Granted 58,800 options to buy @ $0
05/08/2023 4 Saluri Joseph (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Granted 39,200 options to buy @ $0
05/08/2023 4 Plooster Matthew R (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Granted 49,200 options to buy @ $0
05/08/2023 4 FAVORITO TAMARA A (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Granted 39,200 options to buy @ $0
05/08/2023 4 DIXON WENDY L (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Granted 22,500 options to buy @ $0
Granted 36,300 options to buy @ $0
05/08/2023 4 Bode John B (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Granted 58,800 options to buy @ $0
05/08/2023 3 Watton Corey Michael (Director) has filed a Form 3 on ZEVRA THERAPEUTICS, INC.
05/08/2023 3 DIXON WENDY L (Director) has filed a Form 3 on ZEVRA THERAPEUTICS, INC.
05/08/2023 3 Bode John B (Director) has filed a Form 3 on ZEVRA THERAPEUTICS, INC.
03/21/2023 4 SEYMOUR TAMARA A (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Bought 519 shares @ $4.8215, valued at $2.5k
03/15/2023 4 Schafer Joshua (CCO & EVP, Bus. Development) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Bought 2,000 shares @ $4.6089, valued at $9.2k
03/13/2023 4 Plooster Matthew R (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Bought 11,000 shares @ $4.1953, valued at $46.1k
03/13/2023 4 Sangiovanni Timothy J. (SVP, Corporate Controller) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Bought 1,100 shares @ $4.1397, valued at $4.6k
Bought 100 shares @ $4.135, valued at $413.5
03/13/2023 4 Clifton R. LaDuane (CFO, Secretary & Treasurer) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Bought 1,725 shares @ $4.15, valued at $7.2k
03/13/2023 4 Tierney David S (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Bought 5,000 shares @ $4.1463, valued at $20.7k
03/13/2023 4 Pascoe Richard W (CEO) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns: Bought 10,000 shares @ $4.1978, valued at $42k
01/13/2023 4 Clifton R. LaDuane (CFO, Secretary & Treasurer) has filed a Form 4 on KEMPHARM, INC
Txns: Bought 610 shares @ $5.82, valued at $3.6k
Bought 25 shares @ $5.585, valued at $139.6
01/13/2023 4 Pascoe Richard W (CEO) has filed a Form 4 on KEMPHARM, INC
Txns: Bought 9,500 shares @ $5.4399, valued at $51.7k
01/11/2023 4 Clifton R. LaDuane (CFO, Secretary & Treasurer) has filed a Form 4 on KEMPHARM, INC
Txns: Granted 459,726 options to buy @ $4.54, valued at $2.1M
01/11/2023 4 Mickle Christal M M (Chief Product Dev. Officer) has filed a Form 4 on KEMPHARM, INC
Txns: Granted 300,000 options to buy @ $4.54, valued at $1.4M
01/11/2023 4 Guenther Sven (Chief Scientific Officer) has filed a Form 4 on KEMPHARM, INC
Txns: Granted 306,000 options to buy @ $4.54, valued at $1.4M
01/11/2023 4 Schafer Joshua (CCO & EVP, Bus. Development) has filed a Form 4 on KEMPHARM, INC
Txns: Granted 300,000 options to buy @ $4.54, valued at $1.4M
01/11/2023 4 Pascoe Richard W (CEO) has filed a Form 4 on KEMPHARM, INC
Txns: Granted 700,000 options to buy @ $4.54, valued at $3.2M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy